Have a personal or library account? Click to login
Comparative analysis of COVID-19 critically ill patients across four pandemic waves in Greece Cover

References

  1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727–33.
  2. World Health Organization. COVID-19 deaths dashboard. Accessed November 2, 2024. https://data.who.int/dashboards/covid19/deaths.
  3. Ahmad FB, Cisewski JA, Anderson RN. Leading Causes of Death in the US, 2019–2023. JAMA 2024;332:957–8.
  4. Global report investigating novel coronavirus haplotypes. Pango lineages. Published 2021. Accessed December 20, 2021. https://cov-lineages.org/index.html
  5. Malli F, Lampropoulos IC, Perlepe G, Papagiannis D, Gourgoulianis KI. Analysis of SARS-CoV-2 Cases, COVID-19 Outcomes and Vaccinations, during the Different SARS-CoV-2 Variants in Greece. Vaccines (Basel) 2023;11:126.
  6. Government of Greece. COVID-19 information portal. Accessed December 17, 2024. https://covid19.gov.gr
  7. Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med 2021;384:693–704.
  8. Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis 2024;78:e250–e349.
  9. Demoule A, Vieillard Baron A, Darmon M, et al. High-flow nasal cannula in critically III patients with severe COVID-19. Am J Respir Crit Care Med 2020;202:1039–42.
  10. Mathews KS, Soh H, Shaefi S, et al. Prone Positioning and Survival in Mechanically Ventilated Patients with Coronavirus Disease 2019-Related Respiratory Failure. Crit Care Med.2021;49:1026–37.
  11. Kannan S, Shaik Syed Ali P, Sheeza A. Evolving biothreat of variant SARS-CoV-2 - molecular properties, virulence and epidemiology. Eur Rev Med Pharmacol Sci 2021;25:4405–12.
  12. Haas EJ, McLaughlin JM, Khan F, et al. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study. Lancet Infect Dis 2022;22:357–66.
  13. Doidge JC, Gould DW, Ferrando-Vivas P, et al. Trends in Intensive Care for Patients with COVID-19 in England, Wales, and Northern Ireland. Am J Respir Crit Care Med 2021;203:565–74.
  14. Auld SC, Caridi-Scheible M, Robichaux C, Coopersmith CM, Murphy DJ; Emory COVID-19 Quality and Clinical Research Collaborative. Declines in Mortality Over Time for Critically Ill Adults With Coronavirus Disease 2019. Crit Care Med 2020;48:e1382–4.
  15. Carbonell R, Urgelés S, Rodríguez A, et al. Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study. Lancet Reg Health Eur 2021;11:100243.
  16. Karagiannidis C, Windisch W, McAuley DF, Welte T, Busse R. Major differences in ICU admissions during the first and second COVID-19 wave in Germany. Lancet Respir Med 2021; 9:e47–e48.
  17. Demoule A, Fartoukh M, Louis G, et al. (2022) ICU strain and outcome in COVID-19 patients-A multicenter retrospective observational study. PLoS One 2022;17:e0271358.
  18. Routsi C, Kokkoris S, Siempos I, et al. Fewer intubations but higher mortality among intubated coronavirus disease 2019 patients during the second than the first wave. Crit Care Explor 2021;3:e531.
  19. Contou D, Fraissé M, Pajot O, Tirolien JA, Mentec H, Plantefève G. Comparison between first and second wave among critically ill COVID-19 patients admitted to a French ICU: no prognostic improvement during the second wave? Crit Care 2021;25:3.
  20. Haase N, Plovsing R, Christensen S, et al. Changes over time in characteristics, resource use and outcomes among ICU patients with COVID-19-A nationwide, observational study in Denmark. Acta Anaesthesiol Scand 2022;66:987–95.
  21. Naouri D, Vuagnat A, Beduneau G, et al. Trends in clinical characteristics and outcomes of all critically ill COVID-19 adult patients hospitalized in France between March 2020 and June 2021: a national database study. Ann Intensive Care 2023;13:2.
  22. Begum H, Neto AS, Alliegro P, et al. People in intensive care with COVID-19: demographic and clinical features during the first, second, and third pandemic waves in Australia. Med J Aust 2022;217:352–60.
  23. Termorshuizen F, Dongelmans DA, Brinkman S, et al. Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the consecutive stages of the COVID-19 pandemic in the Netherlands, an update. Ann Intensive Care 2024;14:11.
  24. Carrillo-Alcaraz A, Guia M, Lopez-Gomez L, et al. Analysis of combined non-invasive respiratory support in the first six waves of the COVID-19 pandemic. Outcome according to the first respiratory support. Trends Anaesth Crit Care 2023:48:101208.
  25. Guidet B, Jung C, Flaatten H, et al. Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19. Intensive Care Med 2022;48:435–47.
  26. Kokkoris S, Gkoufa A, Maneta E, et al. Older adults with severe coronavirus disease 2019 admitted to intensive care unit; prevalence, characteristics and risk factors for mortality. Minerva Anestesiol 2022; 88:803–14.
  27. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818–9.
  28. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med1996;22:707–10.
  29. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83.
  30. Cecconi M, De Backer D, Antonelli M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 2014;40:1795–815.
  31. National Institutes of Health. IDSA COVID-19 Treatment Guideline updates: Guidelines development-Concomitant medications. Accessed February 24, 2024. https://www.covid19treatmentguidelines.nih.gov/concomitant-medications
  32. Grasselli G, Calfee CS, Camporota L, et al. ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Intensive Care Med 2023;49:727–59.
  33. Navaratnam AV, Gray WK, Day J, Wendon J, Briggs TWR. Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: an observational study using administrative data. Lancet Respir Med 2021;9:397–06.
  34. Xourgia E, Katsaros DE, Xixi NA, et al. Mortality of intubated patients with COVID-19 during first and subsequent waves: a meta-analysis involving 363,660 patients from 43 countries. Expert Rev Respir Med 2022;16:1101–8.
  35. Caldonazo T, Treml RE, Vianna FSL, et al. Outcomes comparison between the first and the subsequent SARS-CoV-2 waves-a systematic review and meta-analysis. Multidiscip Respir Med 2023;18:933.
  36. Anesi GL, Jablonski J, Harhay MO, et al. Characteristics, Outcomes, and Trends of Patients With COVID-19-Related Critical Illness at a Learning Health System in the United States. Ann Intern Med 2021;174:613–21.
  37. Venkatram S, Dileep A, Fortuzi K, Allena N, Diaz-Fuentes G. Comparison of patients admitted to an inner-city intensive care unit across 3 COVID-19 waves. Medicine (Baltimore) 2023;102:e33069.
  38. Auld SC, Harrington KRV, Adelman MW, et al. Trends in ICU mortality from Coronavirus Disease 2019: A Tale of Three Surges. Crit Care Med 2022;50:245–55.
  39. Ganaza-Domingues KLT, Ramos-Milaré ÁCFH, Lera-Nonose DSSL, et al. Effect of Comorbidities on the Mortality of Patients With COVID-19: A Systematic Review of Reviews and Meta-Analyses. Rev Med Virol 2025;35:e70024.
DOI: https://doi.org/10.2478/jccm-2025-0036 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 417 - 428
Submitted on: Feb 17, 2025
Accepted on: Jul 28, 2025
Published on: Oct 31, 2025
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Stelios Kokkoris, Aikaterini Goufa, Dimitrios Tsilivarakis, Fotios Kavallieratos, Georgia Minatsi, Despoina Papadaki, Aikaterini Pranti, Spyros Zakynthinos, Anastasia Kotanidou, Christina Routsi, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.